Alexandre Kiazand | Chief Safety Officer

Alexandre Kiazand, Chief Safety Officer, AstraZeneca


World Drug Safety Congress USA 2019 - Day 1 @ 09:20

Proactive strategy: bringing a lean biotech approach to big pharma using early value assessment - improving safety and lowering cost

World Drug Safety Congress USA 2019 - Day 1 @ 12:00

Approaching Drug-induced Liver Injury (DILI)

How to build an industry-led effort that focuses on clinical aspects of DILI by defining best practices and addressing regulatory gaps for detection, monitoring, management and prevention.
last published: 17/Apr/19 11:55 GMT

back to speakers

Get Involved At World Drug Safety Congress Americas


To Sponsor Or Exhibit

Joseph Sica
t/ +1 646 619 1839




To Speak

Michaela Deitrick
t/ +1 646 619 1799




To Register

Joe McManus
t/ +1 646 619 1774